Building on the U.S.-U.A.E. Business Council’s previous reports on the U.A.E.’s healthcare sector, this updated edition aims to facilitate the involvement of U.S. companies in the next phase of the U.A.E.’s healthcare development by providing relevant updated information about the country’s healthcare sector. This January 2025 edition highlights key developments in attracting innovation through Foreign Direct Investment (FDI) in pre-clinical and clinical trials, genomics, domestic manufacturing, and medical infrastructure. Further advancements in the U.A.E. have been made through AI integration in healthcare and life sciences. The U.A.E.’s continued bilateral partnerships with U.S. hospitals have maintained its medical tourism growth and curated an ecosystem to promote thought leadership.